Clinical Research Directory

Inclusion Criteria: * Participants scheduled to undergo a screening, surveillance or symptomatic colonoscopy with an endoscopist participating in the study phase of the trial. * Male and female participants aged 18 years or older at the time of informed consent. * Participants able to comprehend, sign and date the written informed consent document to participate in the study. Exclusion Criteria: * Emergency and/or inpatient colonoscopies * Participants with inflammatory bowel disease (IBD) * Participants with current Colorectal Cancer (CRC) * Participants with a contraindication for biopsy or polypectomy. These include: * Participants who have not withheld medications pre-disposing to bleeding at time of colonoscopy as per local site /national guidelines. * Participants with a history of haemostasis disorders (haemostasis disorders will include but will not be limited to: participants with haemophilia or other congenitally acquired clotting factor deficiencies, participants with cirrhosis with coagulopathy, participants known to have thrombocytopenia (\<80,000 platelet/ul) and individuals with Von Willebrand's disease or other known platelet malfunction disorders) * Participant is enrolled in another research study with an investigational medicinal product (IMP) or non-IMP that pre-disposes them to bleeding